Medical Device Testing Services Market

ID: MRFR/MED/10831-HCR
131 Pages
Vikita Thakur
Last Updated: June 22, 2026
Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 Market Overview |
    1. 1.1 Study Assumptions & Market Definition |
    2. 1.2 Scope of the Study |
    3. 1.3 Research Methodology
  2. 2 Market Summary & Key Takeaways
  3. 3 Market Dynamics |
    1. 3.1 Market Drivers Analysis | |
      1. 3.1.1 Tightening FDA and EU MDR Regulatory Requirements | |
      2. 3.1.2 Connected-Device and AI/ML Device Proliferation | |
      3. 3.1.3 Outsourcing Shift from In-House to Third-Party Labs | |
      4. 3.1.4 Asia-Pacific Regulatory Harmonization (NMPA, CDSCO, PMDA) | |
      5. 3.1.5 Adoption of In-Silico and Computational Testing Tools | |
      6. 3.1.6 Post-Market Surveillance Expansion under MDR/IVDR | |
      7. 3.1.7 Growth of Combination Products and Drug-Device Hybrids |
    2. 3.2 Market Restraints Analysis | |
      1. 3.2.1 In-Silico Substitution of Legacy Wet-Lab Protocols | |
      2. 3.2.2 Notified-Body and Lab Capacity Bottlenecks | |
      3. 3.2.3 Price Compression from Commoditized Routine Tests | |
      4. 3.2.4 Lengthy Accreditation Timelines for New Entrants | |
      5. 3.2.5 Data-Sovereignty Restrictions on Cross-Border Testing |
    3. 3.3 Market Opportunity Analysis | |
      1. 3.3.1 AI-Driven Autonomous Testing Platforms | |
      2. 3.3.2 Emerging-Market Lab Expansion | |
      3. 3.3.3 Lifecycle Testing-as-a-Service (TaaS) Models | |
      4. 3.3.4 Real-World Evidence Integration | |
      5. 3.3.5 Combination Product and Drug-Device Hybrid Testing |
    4. 3.4 Industry Value Chain Analysis |
    5. 3.5 Porter's Five Forces Analysis
  4. 4 Global Medical Device Testing Services Market Size & Forecast (2021–2035) |
    1. 4.1 Historical Market Size (2021–2025) |
    2. 4.2 Current & Forecast Market Size (2026–2035) |
    3. 4.3 Market Size by Revenue (USD Billion) |
    4. 4.4 Year-over-Year Growth Analysis
  5. 5 Segmentation Analysis |
    1. 5.1 By Service Type | |
      1. 5.1.1 Biocompatibility Testing | |
      2. 5.1.2 Sterility & Microbiology Testing | |
      3. 5.1.3 Electrical Safety & EMC Testing | |
      4. 5.1.4 Material Characterization & Analytical Chemistry | |
      5. 5.1.5 Other Service Types |
    2. 5.2 By Development Phase | |
      1. 5.2.1 Pre-Clinical Testing | |
      2. 5.2.2 Clinical-Phase Testing | |
      3. 5.2.3 Post-Market Surveillance Testing |
    3. 5.3 By Device Class | |
      1. 5.3.1 Class I Devices | |
      2. 5.3.2 Class II Devices | |
      3. 5.3.3 Class III Devices |
    4. 5.4 By End User | |
      1. 5.4.1 Medical Device OEMs | |
      2. 5.4.2 Contract Research Organizations | |
      3. 5.4.3 Academic & Research Institutions | |
      4. 5.4.4 Hospitals & Healthcare Systems
  6. 6 Regional Analysis |
    1. 6.1 North America | |
      1. 6.1.1 United States | |
      2. 6.1.2 Canada | |
      3. 6.1.3 Mexico |
    2. 6.2 Europe | |
      1. 6.2.1 Germany | |
      2. 6.2.2 United Kingdom | |
      3. 6.2.3 France | |
      4. 6.2.4 Italy | |
      5. 6.2.5 Spain | |
      6. 6.2.6 Nordic Countries | |
      7. 6.2.7 Russia | |
      8. 6.2.8 Rest of Europe |
    3. 6.3 Asia-Pacific | |
      1. 6.3.1 China | |
      2. 6.3.2 India | |
      3. 6.3.3 Japan | |
      4. 6.3.4 South Korea | |
      5. 6.3.5 ASEAN | |
      6. 6.3.6 Rest of Asia-Pacific |
    4. 6.4 South America | |
      1. 6.4.1 Brazil | |
      2. 6.4.2 Argentina | |
      3. 6.4.3 Rest of South America |
    5. 6.5 Middle East & Africa | |
      1. 6.5.1 Saudi Arabia | |
      2. 6.5.2 UAE | |
      3. 6.5.3 South Africa | |
      4. 6.5.4 Egypt | |
      5. 6.5.5 Rest of MEA
  7. 7 Competitive Landscape |
    1. 7.1 Market Share Analysis (2025) |
    2. 7.2 Competitive Benchmarking Matrix |
    3. 7.3 Company Profiles | |
      1. 7.3.1 SGS SA | |
      2. 7.3.2 Bureau Veritas | |
      3. 7.3.3 Intertek Group | |
      4. 7.3.4 TÜV SÜD | |
      5. 7.3.5 Eurofins Scientific | |
      6. 7.3.6 UL Solutions | |
      7. 7.3.7 Element Materials Technology | |
      8. 7.3.8 NAMSA | |
      9. 7.3.9 Toxikon Corporation | |
      10. 7.3.10 WuXi AppTec
  8. 8 Future Outlook & Strategic Recommendations (2026–2035) |
    1. 8.1 AI-Integrated Testing Workflows |
    2. 8.2 Platform Economics and Lab Consolidation |
    3. 8.3 Sustainability and Green Chemistry in Testing Protocols |
    4. 8.4 Real-World Performance Monitoring as a Testing Service
  9. 9 Recent Developments & News
  10. 10 Frequently Asked Questions (FAQs)
  11. 11 Report Scope & Methodology |
    1. 11.1 Study Period & Base Year |
    2. 11.2 Data Sources & Citations |
    3. 11.3 Abbreviations
  12. 12 LIST OF TABLES |
  13. TABLE 1 Global Medical Device Testing Services Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
  14. TABLE 2 Global Medical Device Testing Services Market — Year-over-Year Growth Analysis, 2021–2035 |
  15. TABLE 3 Global Medical Device Testing Services Market — Driver Impact Analysis |
  16. TABLE 4 Global Medical Device Testing Services Market — Restraint Impact Analysis |
  17. TABLE 5 Global Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  18. TABLE 6 Global Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  19. TABLE 7 Global Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  20. TABLE 8 Global Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  21. TABLE 9 Global Medical Device Testing Services Market Size, by Region, 2021–2035 (USD Billion) |
  22. TABLE 10 North America Medical Device Testing Services Market Size, by Country, 2021–2035 (USD Billion) |
  23. TABLE 11 Europe Medical Device Testing Services Market Size, by Country, 2021–2035 (USD Billion) |
  24. TABLE 12 Asia-Pacific Medical Device Testing Services Market Size, by Country, 2021–2035 (USD Billion) |
  25. TABLE 13 South America Medical Device Testing Services Market Size, by Country, 2021–2035 (USD Billion) |
  26. TABLE 14 Middle East & Africa Medical Device Testing Services Market Size, by Country, 2021–2035 (USD Billion) |
  27. TABLE 15 Competitive Benchmarking Matrix — Global Medical Device Testing Services Market, 2025 |
  28. TABLE 16 Company Profiles — Key Players, Global Medical Device Testing Services Market |
  29. TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
  30. TABLE 18 North America Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  31. TABLE 19 North America Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  32. TABLE 20 North America Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  33. TABLE 21 North America Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  34. TABLE 22 Europe Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  35. TABLE 23 Europe Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  36. TABLE 24 Europe Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  37. TABLE 25 Europe Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  38. TABLE 26 Asia-Pacific Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  39. TABLE 27 Asia-Pacific Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  40. TABLE 28 Asia-Pacific Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  41. TABLE 29 Asia-Pacific Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  42. TABLE 30 South America Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  43. TABLE 31 South America Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  44. TABLE 32 South America Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  45. TABLE 33 South America Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  46. TABLE 34 Middle East & Africa Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  47. TABLE 35 Middle East & Africa Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  48. TABLE 36 Middle East & Africa Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  49. TABLE 37 Middle East & Africa Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  50. TABLE 38 United States Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  51. TABLE 39 United States Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  52. TABLE 40 United States Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  53. TABLE 41 United States Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  54. TABLE 42 Canada Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  55. TABLE 43 Canada Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  56. TABLE 44 Canada Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  57. TABLE 45 Canada Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  58. TABLE 46 Mexico Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  59. TABLE 47 Mexico Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  60. TABLE 48 Mexico Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  61. TABLE 49 Mexico Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  62. TABLE 50 Germany Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  63. TABLE 51 Germany Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  64. TABLE 52 Germany Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  65. TABLE 53 Germany Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  66. TABLE 54 United Kingdom Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  67. TABLE 55 United Kingdom Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  68. TABLE 56 United Kingdom Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  69. TABLE 57 United Kingdom Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  70. TABLE 58 France Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  71. TABLE 59 France Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  72. TABLE 60 France Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  73. TABLE 61 France Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  74. TABLE 62 Italy Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  75. TABLE 63 Italy Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  76. TABLE 64 Italy Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  77. TABLE 65 Italy Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  78. TABLE 66 Spain Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  79. TABLE 67 Spain Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  80. TABLE 68 Spain Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  81. TABLE 69 Spain Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  82. TABLE 70 China Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  83. TABLE 71 China Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  84. TABLE 72 China Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  85. TABLE 73 China Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  86. TABLE 74 India Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  87. TABLE 75 India Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  88. TABLE 76 India Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  89. TABLE 77 India Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  90. TABLE 78 Japan Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  91. TABLE 79 Japan Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  92. TABLE 80 Japan Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  93. TABLE 81 Japan Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  94. TABLE 82 South Korea Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  95. TABLE 83 South Korea Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  96. TABLE 84 South Korea Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  97. TABLE 85 South Korea Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  98. TABLE 86 Brazil Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  99. TABLE 87 Brazil Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  100. TABLE 88 Brazil Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  101. TABLE 89 Brazil Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  102. TABLE 90 Saudi Arabia Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  103. TABLE 91 Saudi Arabia Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  104. TABLE 92 Saudi Arabia Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  105. TABLE 93 Saudi Arabia Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  106. TABLE 94 UAE Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  107. TABLE 95 UAE Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  108. TABLE 96 UAE Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  109. TABLE 97 UAE Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  110. TABLE 98 South Africa Medical Device Testing Services Market Size, by Service Type, 2021–2035 (USD Billion) |
  111. TABLE 99 South Africa Medical Device Testing Services Market Size, by Development Phase, 2021–2035 (USD Billion) |
  112. TABLE 100 South Africa Medical Device Testing Services Market Size, by Device Class, 2021–2035 (USD Billion) |
  113. TABLE 101 South Africa Medical Device Testing Services Market Size, by End User, 2021–2035 (USD Billion) |
  114. TABLE 102 Report Scope & Methodology Summary |
  115. TABLE 103 Detailed Sources and Citations
  116. 13 LIST OF FIGURES |
  117. FIGURE 1 Medical Device Testing Services Market Dynamics — Drivers, Restraints & Opportunities |
  118. FIGURE 2 Industry Value Chain Analysis — Medical Device Testing Services |
  119. FIGURE 3 Porter's Five Forces Analysis — Medical Device Testing Services Market |
  120. FIGURE 4 Global Medical Device Testing Services Market Size Trend & Forecast, 2021–2035 (USD Billion) |
  121. FIGURE 5 Medical Device Testing Services Market Share, by Service Type, 2024 |
  122. FIGURE 6 Medical Device Testing Services Market Share, by Development Phase, 2024 |
  123. FIGURE 7 Medical Device Testing Services Market Share, by Device Class, 2024 |
  124. FIGURE 8 Medical Device Testing Services Market Share, by End User, 2024 |
  125. FIGURE 9 Medical Device Testing Services Market Share, by Region, 2024 |
  126. FIGURE 10 North America Medical Device Testing Services Market Size, by Country, 2021–2035 |
  127. FIGURE 11 Europe Medical Device Testing Services Market Size, by Country, 2021–2035 |
  128. FIGURE 12 Asia-Pacific Medical Device Testing Services Market Size, by Country, 2021–2035 |
  129. FIGURE 13 South America Medical Device Testing Services Market Size, by Country, 2021–2035 |
  130. FIGURE 14 Middle East & Africa Medical Device Testing Services Market Size, by Country, 2021–2035 |
  131. FIGURE 15 Competitive Landscape — Market Share of Top 10 Players, 2025 |
  132. FIGURE 16 Competitive Positioning Matrix — Medical Device Testing Services Market

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
Service TypeBiocompatibility Testing; Sterility & Microbiology Testing; Electrical Safety & EMC Testing; Material Characterization & Analytical Chemistry; Other Service TypesBiocompatibility Testing (32.0% share, 2024)Electrical Safety & EMC Testing (14.5% CAGR)
Development PhasePre-Clinical Testing; Clinical-Phase Testing; Post-Market Surveillance TestingPre-Clinical Testing (47.5% share, 2024)Post-Market Surveillance Testing (13.8% CAGR)
Device ClassClass I; Class II; Class IIIClass II (55.0% share, 2024)Class III (14.8% CAGR)
End UserMedical Device Testing Services Market OEMs; Contract Research Organizations; Academic & Research Institutions; Hospitals & Healthcare SystemsMedical Device Testing Services Market OEMs (61.0% share, 2024)Contract Research Organizations (12.8% CAGR)
GeographyNorth America; Europe; Asia-Pacific; South America; Middle East & AfricaNorth America (39.2% share, 2024)Asia-Pacific (13.0% CAGR)

 

 

Market Segmentation Overview

By Service Type

Sub-SegmentKey Trend
Biocompatibility TestingShift toward in-silico toxicology supplements under revised ISO 10993-18 guidance.
Sterility & Microbiology TestingGrowing demand from the proliferation of single-use surgical devices
Electrical Safety & EMC TestingRapid expansion driven by connected wearables and AI-enabled implantables
Material Characterization & Analytical ChemistryIncreasing complexity of extractables/leachables programs for novel polymer materials
Other Service TypesShelf-life, package integrity, and human factors/usability testing are gaining prominence.

 

Biocompatibility testing remains the foundational service category, required across virtually all device classifications that involve patient contact. Electrical safety and EMC testing is gaining share fastest as wireless connectivity and AI-driven functionality become standard features in new-generation devices, requiring multifaceted IEC 60601 compliance suites.

By the Development Phase

Sub-SegmentKey Trend
Pre-Clinical TestingFront-loaded regulatory evidence strategy drives the majority of spending
Clinical-Phase TestingGCP-compliant device performance validation is rising with combination products.
Post-Market Surveillance TestingEU MDR PSUR/PMCF obligations and FDA NEST framework expand ongoing testing mandates.

 

Pre-clinical testing commands the largest share because most regulatory pathways globally require substantial bench, animal, and analytical evidence before any first-in-human study can proceed. Post-market surveillance is accelerating as regulators shift from episodic complaint review to continuous performance monitoring models.

By Device Class

Sub-SegmentKey Trend
Class I DevicesBaseline compliance testing with low per-device spend
Class II DevicesBroadest product population drives the highest aggregate testing volumes.
Class III DevicesComplex implantables and AI/ML diagnostics require extensive multi-year programs.

 

Class II devices generate the largest total testing revenue due to the sheer breadth of products — from powered surgical tools to diagnostic accessories — that require 510(k) substantial-equivalence evidence. Class III device testing grows fastest, reflecting the rising complexity and regulatory burden of high-risk implantable and life-sustaining products.

By End User

Sub-SegmentKey Trend
Medical Device Testing Services Market OEMsDirect regulatory submission responsibility sustains dominant spend
Contract Research OrganizationsCRO-mediated outsourcing is accelerating among start-ups and mid-tier OEMs
Academic & Research InstitutionsInvestigator-initiated device studies and translational research demand
Hospitals & Healthcare SystemsIn-house reprocessing validation and point-of-care device verification

 

OEMs remain the largest end-user segment because they bear direct accountability for every test in their regulatory submission dossier. CROs represent the fastest-growing channel as smaller device companies delegate entire multi-site testing programs under single master service agreements.

By Geography

Sub-SegmentKey Trend
North AmericaDense FDA-registered lab infrastructure and deepest OEM concentration
EuropeMDR/IVDR re-certification backlog is sustaining elevated compliance testing volumes
Asia-PacificNMPA, CDSCO, and PMDA reform driving fastest regional growth
South AmericaANVISA GMP enforcement is creating captive import-driven testing demand
Middle East & AfricaEarly-stage regulatory formalization; heavy reliance on overseas lab capacity

 

North America leads globally owing to the scale of the FDA-regulated device ecosystem and the concentration of accredited testing labs. Asia-Pacific is the fastest-growing region as China, India, and Japan simultaneously modernize their device regulatory frameworks, unlocking fresh testing demand that global and domestic labs are racing to serve.